Latest BCRX reports update at 2024-05-07: 2024-Q12023-Q42023-Q1
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 6.17 -0.96%

BioCryst Pharmaceuticals EV/EBITDA Ratio 2011-2024 | BCRX

Annual EV/EBITDA Ratio BioCryst Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-13.8 -8.2 -2.93 -9.96 -6.82 -9.85 -13 -14.4 -19.1 -2.77 -3.52

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.77 -19.1 -9.49